A new way of looking at the brains of multiple sclerosis (MS) patients could greatly enhance doctors’ ability to select the best therapy for each person. Researchers from
Statistics from the NHS’s self-reporting safety database revealed there have been more than 13,000 “death” cases in the last three years. The National Reporting and Learning System (NRLS) was
Buprenorphine-naloxone (buprenorphine), a highly effective, evidence-based treatment for opioid use disorder (OUD), is difficult to access in states with high rates of death associated with OUD, according to
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. The
Parkinson’s disease (PD) is a chronic, progressive neurological disorder affecting approximately 6 million people globally and is expected to double by 2040. PD leads to disabling motor features
Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with advanced BRCA- or PALB2-mutated pancreatic cancer sensitive to platinum-based chemotherapy,
Revealed: Interactive map shows the areas of England where cancer patients are most likely to die within a year of being diagnosed Figures from the Office for National
Doctors are told to ‘resist’ patients trying to stock up on medication in fear of running out after Brexit Health officials have warned doctors not to over-prescribe in
Patients taking diuretics are often at risk for low potassium levels, which can put patients at an increased risk of death from cardiac arrhythmias or other causes. However,
MONDAY, Feb. 11, 2019 — Heart patients prescribed opioid painkillers when they leave the hospital may be less likely to get follow-up care and slightly more likely to
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
